{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05794191",
            "orgStudyIdInfo": {
                "id": "B1851217"
            },
            "organization": {
                "fullName": "Pfizer",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study To Learn About The Effects Of Pneumococcal Vaccine In People With HIV",
            "officialTitle": "Assessment of 13-valent Pneumococcal Conjugate Vaccine Effectiveness Among People With HIV",
            "therapeuticArea": [
                "Respiratory",
                "Infectious Diseases"
            ],
            "study": "a-study-to-learn-about-the-effects-of-pneumococcal-vaccine-in-people-with-hiv"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-12",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-03-22",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-10-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-10-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-03-20",
            "studyFirstSubmitQcDate": "2023-03-20",
            "studyFirstPostDateStruct": {
                "date": "2023-04-03",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-12-21",
            "lastUpdatePostDateStruct": {
                "date": "2023-12-22",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Pfizer",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to learn about how well a vaccine (Prevnar 13, PCV13) works in preventing disease in adults with HIV.\n\nThe diseases studied are pneumonia. Mostly the ones caused by the bacteria - pneumococcus. This study also evaluates the type of pneumonia that is spread into the bloodstream.\n\nAll participants in the study will be identified in health care databases. Adults with HIV will be identified by looking for a medical diagnosis that has confirmed HIV from the databases. Vaccination will be identified in the databases by looking for vaccine administration or for PCV13.\n\nParticipants will be followed in the databases to see if they have one of the diseases mentioned above or not. The number of vaccinated participants with the diseases will be compared to the number participants without the vaccines but with the diseases. This will help to understand how well the vaccine worked."
        },
        "conditionsModule": {
            "conditions": [
                "HIV",
                "Pneumonia",
                "Infections, Pneumococcal"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "RETROSPECTIVE"
            },
            "enrollmentInfo": {
                "count": 1,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Persons living with HIV (PLWH)",
                    "description": "Adults with HIV",
                    "interventionNames": [
                        "Biological: Vaccine Administration"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BIOLOGICAL",
                    "name": "Vaccine Administration",
                    "description": "PCV13 administration",
                    "armGroupLabels": [
                        "Persons living with HIV (PLWH)"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Incidence of invasive pneumococcal disease",
                    "description": "Medical record for IPD diagnosed by ICD9 or ICD10 code",
                    "timeFrame": "July,1 2014 - September 30, 2022 (duration of study)"
                },
                {
                    "measure": "Incidence of all cause pneumonia",
                    "description": "Incidence of all cause pneumonia diagnosed by ICD9 - ICD10 code",
                    "timeFrame": "July 1, 2014 - September 30, 2022 (duration of study)"
                },
                {
                    "measure": "Incidence of pneumococcal pneumonia",
                    "description": "Diagnosis of pneumococcal pneumonia by ICD9 / ICD10 code",
                    "timeFrame": "July 1, 2014 - September 30, 2022 (duration of study)"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Incidence of pneumococcal pneumonia or unspecified pneumonia",
                    "timeFrame": "July 1, 2014 - September 30, 2022 (timeframe of study)"
                },
                {
                    "measure": "Incidence of pneumonia of unspecified causes",
                    "timeFrame": "July 1, 2014 - September 30, 2022 (timeframe of study)"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. HIV infection defined as at least one inpatient or \u22652 outpatient codes related to HIV at least 30 days but no more than 730 days apart\n2. At least 18 years of age at the time of the first HIV-related code\n3. At least six months of continuous enrollment in medical and pharmacy plans after the first HIV-related code\n\nExclusion Criteria:\n\n1. Evidence of PCV13 vaccination before the first HIV-related code",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "People with HIV in a healthcare administrative database",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Pfizer CT.gov Call Center",
                    "role": "CONTACT",
                    "phone": "1-800-718-1021",
                    "email": "ClinicalTrials.gov_Inquiries@pfizer.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Pfizer CT.gov Call Center",
                    "affiliation": "Pfizer",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Pfizer",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10017",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "To obtain contact information for a study center near you, click here.",
                    "url": "https://pmiform.com/clinical-trial-info-request?StudyID=B1851217"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO",
            "description": "Pfizer will provide access to individual de-identified participant data and related study documents (e.g. protocol, Statistical Analysis Plan (SAP), Clinical Study Report (CSR)) upon request from qualified researchers, and subject to certain criteria, conditions, and exceptions. Further details on Pfizer's data sharing criteria and process for requesting access can be found at: https://www.pfizer.com/science/clinical_trials/trial_data_and_results/data_requests."
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000011008",
                    "term": "Pneumococcal Infections"
                }
            ],
            "ancestors": [
                {
                    "id": "D000007239",
                    "term": "Infections"
                },
                {
                    "id": "D000013290",
                    "term": "Streptococcal Infections"
                },
                {
                    "id": "D000016908",
                    "term": "Gram-Positive Bacterial Infections"
                },
                {
                    "id": "D000001424",
                    "term": "Bacterial Infections"
                },
                {
                    "id": "D000001423",
                    "term": "Bacterial Infections and Mycoses"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M3522",
                    "name": "Acquired Immunodeficiency Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "M18250",
                    "name": "HIV Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M10283",
                    "name": "Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M6368",
                    "name": "Communicable Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M13904",
                    "name": "Pneumonia",
                    "relevance": "LOW"
                },
                {
                    "id": "M13898",
                    "name": "Pneumococcal Infections",
                    "asFound": "Infections, Pneumococcal",
                    "relevance": "HIGH"
                },
                {
                    "id": "M16080",
                    "name": "Streptococcal Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M4722",
                    "name": "Bacterial Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M19252",
                    "name": "Gram-Positive Bacterial Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M12136",
                    "name": "Mycoses",
                    "relevance": "LOW"
                },
                {
                    "id": "M4721",
                    "name": "Bacterial Infections and Mycoses",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC01",
                    "name": "Infections"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M17360",
                    "name": "Vaccines",
                    "relevance": "LOW"
                },
                {
                    "id": "M412",
                    "name": "Heptavalent Pneumococcal Conjugate Vaccine",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}